TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

VALINK THERAPEUTICS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

VALINK THERAPEUTICS

ST13

US500000079397608

Classe

1, 5, 42

Pedido

79397608

Registro

7757032

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

32

Atualização mais recente

01/12/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42

Data de depósito

05/03/2024

Data de registro

15/04/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/04/2025

Última transação

01/12/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

98

Localização do titular

US

Examinador

SPILS,CAROL A

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Valink Therapeutics Inc.

Representantes

Matthew A. Homyk Blank Rome LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals for use in industry and science; biological preparations for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodies, other than for medical use; proteins for binding antibodies, other than for medical use; immunological antibodies, other than for medical use; chemical substances for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical substances for use in the production of drugs; chemicals for use in scientific research, other than medical or veterinary; chemicals for use in biotechnological product development

Classe 5

Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of cancer in humans and animals; pharmaceutical drugs for the prevention and treatment of cancer in humans and animals; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use for the treatment of cancer; antibodies for medical purposes

Classe 42

Scientific and technological services and research and design relating thereto in the fields of pharmaceutical, biomedical, and chemical sciences; biotechnology research; biological research; clinical research in the field of radiology and chemotherapy; medical research; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; scientific research relating to biotechnology; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemical research services of biochemistry drugs; biochemistry consultancy; biochemistry research services; biochemical research and development; research and development in the field of biotechnology; biochemical engineering services; scientific laboratory services; biochemical research laboratory services; medical research laboratory services; medical research laboratories; providing information relating to scientific research in the fields of biochemistry and biotechnology; consultancy in the field of pharmaceutical research; scientific consultancy in the field of biotechnology; consultancy relating to research and development in the field of therapeutics

Publicações

Histórico de despachos e eventos da marca no USPTO.

32 publicações encontradas

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

30/11/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

22/11/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/11/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/11/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/11/2025

FIMP

FINAL DISPOSITION PROCESSED

04/11/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

16/07/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

04/07/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

16/05/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

15/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

15/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/02/2025

PUBO

PUBLISHED FOR OPPOSITION

25/02/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/02/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

13/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

13/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

13/12/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

13/12/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

13/12/2024

RFNT

REFUSAL PROCESSED BY IB

17/11/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

29/10/2024

RFRR

REFUSAL PROCESSED BY MPU

15/10/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/10/2024

CNRT

NON-FINAL ACTION WRITTEN

09/10/2024

DOCK

ASSIGNED TO EXAMINER

18/09/2024

MAFR

APPLICATION FILING RECEIPT MAILED

20/06/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/06/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

13/06/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace VALINK THERAPEUTICS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.